The prevailing agreement suggests that Lp‐PLA2 catalyzes the breakdown of oxidized phospholipids, creating proinflammatory compounds that contribute to endothelial dysfunction, inflammation within plaques, and the development of necrotic cores within them. This evidence concerns the gene PLA2G7 and endothelial dysfunction.